Evidence map›Paper›PMID 42713927›Full record

ArticleMolecular genetics & genomic medicine2026

Costello Syndrome Associated With Somatic Mosaicism of Rare p.Gly13Asp HRAS Variant: Expanding the Phenotypic Spectrum.

Jovan Lalosevic, Katarina Djordjevic, Mirjana Gajic-Veljic, Sonja Pavlovic, Vladimir Gasic, Marina Andjelkovic, Milos Nikolic

Abstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jovan LalosevicClinic of Dermatology and Venereology, University Clinical Center of Serbia, Belgrade, Serbia.ORCID https://orcid.org/0000-0003-4830-7514
Katarina DjordjevicClinic of Dermatology and Venereology, University Clinical Center of Serbia, Belgrade, Serbia.ORCID https://orcid.org/0009-0005-2146-4861
Mirjana Gajic-VeljicClinic of Dermatology and Venereology, University Clinical Center of Serbia, Belgrade, Serbia.
Sonja PavlovicInstitute of Molecular Genetics and Genetic Engineering (IMGGE), University of Belgrade, Belgrade, Serbia.
Vladimir GasicInstitute of Molecular Genetics and Genetic Engineering (IMGGE), University of Belgrade, Belgrade, Serbia.ORCID https://orcid.org/0000-0001-9589-5502
Marina AndjelkovicInstitute of Molecular Genetics and Genetic Engineering (IMGGE), University of Belgrade, Belgrade, Serbia.ORCID https://orcid.org/0000-0002-4086-6197
Milos NikolicClinic of Dermatology and Venereology, University Clinical Center of Serbia, Belgrade, Serbia.ORCID https://orcid.org/0000-0002-3926-5394

Funding

Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja 175065
6 · The paper itself

Abstract

backgroundCostello syndrome (CS) is a rare RASopathy, mostly caused by de novo heterozygous pathogenic variants in the HRAS gene. Over 80% of cases involve the germline p.Gly12Ser variant, resulting in a fairly uniform phenotype of neuro-cardio-facio-cutaneous involvement with an increased risk of malignancy. Consequences of other rare HRAS variants are less well understood due to the limited number of reported cases.

methodsAn adult, young woman was referred due to sparse, slow-growing scalp hair, Blaschko-linear hyperpigmentation, acanthosis nigricans, palmoplantar hyperkeratosis, and joint hyperlaxity. Molecular, imaging, and detailed laboratory studies were performed.

resultsAlthough initial clinical exome- and whole-exome sequencing (WES) were inconclusive, indicating possible mosaicism, subsequent WES from hair-derived DNA samples revealed somatic mosaicism for the rare HRAS p.Gly13Asp variant. Brain MRIs showed a cerebral cavernoma, while cardiological evaluation, urinalysis, abdominal, and pelvic ultrasound were unremarkable. Nevertheless, she remains under close follow-up.

conclusionAmong the ten reported individuals carrying the p.Gly13Asp variant, our patient is only the second with confirmed mosaicism and the fifth mosaic CS case described to date. This case expands the phenotypic spectrum of CS and highlights the need for multi-tissue analysis in attenuated or atypical presentations to ensure a correct diagnosis, oncological risk assessment, and informed genetic and reproductive counseling.

Indexed as

Costello SyndromeMosaicismMutation, MissensePhenotypeProto-Oncogene Proteins p21(ras)AdultFemaleHumansHRAS protein, humanProto-Oncogene Proteins p21(ras)Blaschko‐linear hyperpigmentationCostello syndromeHRAS p.Gly13Asp variantRASopathiessomatic mosaicism

Identifiers

PMID42713927
PMCPMC13556161

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.